Si Jin Selected Research

rhodioloside

8/2021	Salidroside protects cardiac function in mice with diabetic cardiomyopathy via activation of mitochondrial biogenesis and SIRT3.
1/2020	Salidroside-Mediated Autophagic Targeting of Active Src and Caveolin-1 Suppresses Low-Density Lipoprotein Transcytosis across Endothelial Cells.
1/2019	Rhodiola and salidroside in the treatment of metabolic disorders.
1/2018	Salidroside Attenuates High-Fat Diet-Induced Nonalcoholic Fatty Liver Disease via AMPK-Dependent TXNIP/NLRP3 Pathway.
2/2016	A novel mechanism of action for salidroside to alleviate diabetic albuminuria: effects on albumin transcytosis across glomerular endothelial cells.
9/2015	Salidroside improves endothelial function and alleviates atherosclerosis by activating a mitochondria-related AMPK/PI3K/Akt/eNOS pathway.
7/2015	Salidroside ameliorates insulin resistance through activation of a mitochondria-associated AMPK/PI3K/Akt/GSK3β pathway.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Si Jin Research Topics

Disease

11	Atherosclerosis 01/2022 - 01/2014
7	Insulin Resistance 01/2022 - 07/2015
5	Type 2 Diabetes Mellitus (MODY) 01/2022 - 07/2011
3	Metabolic Diseases (Metabolic Disease) 01/2020 - 07/2011
3	Diabetes Mellitus 01/2019 - 12/2016
3	Neoplasms (Cancer) 01/2019 - 01/2014
2	Atherosclerotic Plaque (Atheroma) 01/2022 - 09/2015
2	Gestational Diabetes (Gestational Diabetes Mellitus) 01/2022 - 01/2020
2	Obesity 01/2021 - 01/2018
2	Hyperglycemia 01/2020 - 01/2019
1	Body Weight (Weight, Body) 01/2022
1	Diabetic Cardiomyopathies 08/2021
1	Type 2 Maturity-Onset Diabetes of the Young 01/2021
1	Mason-Type Diabetes 01/2021
1	COVID-19 12/2020
1	Hyperhomocysteinemia 08/2019
1	Memory Disorders (Memory Loss) 08/2019
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2019
1	Neoplasm Metastasis (Metastasis) 01/2018
1	Adenocarcinoma of Lung 01/2018
1	Colorectal Neoplasms (Colorectal Cancer) 01/2018
1	Non-alcoholic Fatty Liver Disease 01/2018
1	Carcinogenesis 01/2018
1	Rare Diseases (Rare Disease) 02/2016
1	Albuminuria 02/2016
1	Proteinuria 02/2016
1	Diabetic Nephropathies (Diabetic Nephropathy) 02/2016
1	Fatty Liver 07/2015
1	Iron Deficiencies 07/2015
1	Hepatocellular Carcinoma (Hepatoma) 03/2015
1	Asthma (Bronchial Asthma) 02/2014
1	Respiratory Hypersensitivity 02/2014
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2014
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2014
1	Hyperlipidemias (Hyperlipidemia) 07/2011
1	Sclerosis 09/2009
1	Nasal Polyps (Nasal Polyp) 10/2007

Drug/Important Bio-Agent (IBA)

9	LipidsIBA 01/2022 - 09/2009
8	oxidized low density lipoproteinIBA 01/2022 - 01/2014
7	rhodiolosideIBA 08/2021 - 07/2015
6	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2004
5	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 02/2016
5	Lipoproteins (Lipoprotein)IBA 01/2020 - 01/2014
5	LDL Lipoproteins (beta Lipoproteins)IBA 01/2020 - 05/2014
4	Blood Glucose (Blood Sugar)IBA 01/2022 - 07/2015
4	Caveolin 1IBA 01/2022 - 02/2016
3	Insulin (Novolin)FDA Link 01/2022 - 07/2015
2	Apolipoproteins E (ApoE)IBA 01/2022 - 05/2014
2	ApolipoproteinsIBA 01/2020 - 01/2019
2	AMP-Activated Protein KinasesIBA 01/2020 - 01/2018
2	HomocysteineIBA 08/2019 - 09/2009
2	LDL Receptors (LDL Receptor)IBA 01/2019 - 09/2015
2	CytokinesIBA 01/2019 - 02/2014
2	Biological ProductsIBA 01/2019 - 03/2015
2	InflammasomesIBA 01/2019 - 01/2018
2	Therapeutic UsesIBA 01/2018 - 07/2015
2	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 09/2015 - 01/2004
2	CeramidesIBA 01/2014 - 09/2009
2	Messenger RNA (mRNA)IBA 10/2007 - 01/2004
1	Histones (Histone)IBA 01/2022
1	Streptozocin (Streptozotocin)FDA Link 08/2021
1	Sirtuin 3IBA 08/2021
1	GlucokinaseIBA 01/2021
1	LeptinIBA 01/2021
1	Intravenous Immunoglobulins (IVIG)FDA Link 12/2020
1	Immunoglobulins (Immunoglobulin)IBA 12/2020
1	Sirolimus (Rapamycin)FDA Link 01/2020
1	GlycosidesIBA 01/2020
1	bafilomycin A1IBA 01/2020
1	Class III Phosphatidylinositol 3-KinasesIBA 01/2020
1	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 01/2020
1	Phosphotransferases (Kinase)IBA 01/2020
1	Liraglutide FDA Link 08/2019
1	Interleukin-1 (Interleukin 1)IBA 01/2019
1	Long Noncoding RNAIBA 01/2018
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2018
1	Biomarkers (Surrogate Marker)IBA 12/2017
1	Palmitic Acid (Hexadecanoic Acid)IBA 01/2017
1	HomoharringtonineIBA 02/2016
1	AlbuminsIBA 02/2016
1	IronIBA 07/2015
1	piperlongumineIBA 03/2015
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 07/2014
1	C-Reactive ProteinIBA 05/2014
1	Tacrolimus Binding Proteins (FKBP)IBA 02/2014
1	tacrolimus binding protein 1BIBA 02/2014
1	CalciumIBA 02/2014
1	Ryanodine Receptor Calcium Release Channel (Ryanodine Receptor)IBA 02/2014
1	AntioxidantsIBA 01/2014
1	Adenosine Triphosphate (ATP)IBA 01/2014
1	Oxidants (Oxidizing Agents)IBA 01/2014
1	Interleukin-6 (Interleukin 6)IBA 07/2011
1	AdiponectinIBA 07/2011
1	FlavonoidsIBA 07/2011
1	Superoxides (Superoxide)IBA 09/2009
1	NADPH Oxidases (NAD(P)H oxidase)IBA 09/2009

Therapy/Procedure

1	Oral Administration 01/2022
1	Therapeutics 01/2021
1	Drug Therapy (Chemotherapy) 10/2018
1	Traditional Medicine (Folk Remedies) 12/2016